Aerovate Therapeutics Statistics

Total Valuation

AVTE has a market cap or net worth of $617.72 million. The enterprise value is $495.96 million.

Market Cap	617.72M
Enterprise Value	495.96M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, after market close.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

AVTE has 27.86 million shares outstanding. The number of shares has increased by 7.60% in one year.

Shares Outstanding	27.86M
Shares Change (YoY)	+7.60%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	103.50%
Float	10.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.64
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.01.

Current Ratio	7.04
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.60% and return on invested capital (ROIC) is -73.92%.

Return on Equity (ROE)	-61.60%
Return on Assets (ROA)	-55.10%
Return on Capital (ROIC)	-73.92%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTE has paid $56,000 in taxes.

Income Tax	56,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.04% in the last 52 weeks. The beta is 1.23, so AVTE's price volatility has been higher than the market average.

Beta (1Y)	1.23
52-Week Price Change	+14.04%
50-Day Moving Average	24.30
200-Day Moving Average	17.93
Relative Strength Index (RSI)	39.57
Average Volume (30 Days)	148,353

Short Selling Information

The latest short interest is 993,087, so 3.56% of the outstanding shares have been sold short.

Short Interest	993,087
Short Previous Month	903,698
Short % of Shares Out	3.56%
Short % of Float	9.83%
Short Ratio (days to cover)	6.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-81.41M
Pretax Income	-75.47M
Net Income	-75.52M
EBITDA	-75.37M
EBIT	-75.47M
Earnings Per Share (EPS)	-$2.87

Full Income Statement

Balance Sheet

The company has $122.44 million in cash and $675,000 in debt, giving a net cash position of $121.76 million or $4.37 per share.

Cash & Cash Equivalents	122.44M
Total Debt	675,000
Net Cash	121.76M
Net Cash Per Share	$4.37
Equity / Book Value	109.46M
Book Value Per Share	3.93
Working Capital	106.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.78 million and capital expenditures -$142,000, giving a free cash flow of -$56.92 million.

Operating Cash Flow	-56.78M
Capital Expenditures	-142,000
Free Cash Flow	-56.92M
FCF Per Share	-$2.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVTE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.60%
Shareholder Yield	-7.60%
Earnings Yield	-12.23%
FCF Yield	-9.21%

Analyst Forecast

The average price target for AVTE is $50.00, which is 125.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$50.00
Price Target Difference	125.53%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-17.28%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2